en laxminarayan day 1

Post on 23-Jul-2016

229 Views

Category:

Documents

3 Downloads

Preview:

Click to see full reader

DESCRIPTION

http://www.cddep.org/sites/default/files/en_laxminarayan_day_1.pdf

TRANSCRIPT

cembrola
CDDEP1

Objective

Develop actionable national strategies to address the challenge of antibiotic resistance in five low‐ and middle-income countries

ChinaIndiaKenyaSouth AfricaVietnam

Specific Aims

Develop the evidence base for policy action on antibiotic resistanceIdentify policy opportunities where research dissemination, advocacy, and information can have the greatest impact in slowing the development and spread of resistance.

Steps

Create country profiles of baseline resistance, antibiotic use and burden of resistanceAssess the health and economic consequences of antibiotic resistanceDevelop mathematical models of specific approaches to delay emergence of antibiotic resistanceConstitute GARP National Working Groups

Other objectives

Create an IT platform for a global antibiotic resistance atlasInternational conference to compare policy approaches across the five target countries and to discuss the relevance of these approaches to other countries outside the initial partnership

Second Phase

Dissemination of national strategiesPolicy communicationsFurther research

Objectives for this meeting

How serious a problem is antibiotic resistance in Vietnam?What are the primary drivers of resistance?What policies could both help reduce the

Suboptimal use of antibioticsNeed for antibioticsEmergence and spread of resistance

www.extendingthecure.org

60 Years Later

Leading Infectious Killers Millions of deaths, worldwide, all ages

Upto 55% resistance to penicillin in S.

pneumoniae in some areas

Leading Infectious Killers Millions of deaths, worldwide, all ages

Resistance to all currently marketed

retrovirals

Leading Infectious Killers Millions of deaths, worldwide, all ages

Salmonella typhii : Epidemics of

multiresistant strains in 11 countries since 1989

Leading Infectious Killers Millions of deaths, worldwide, all ages

Mycobacterium tuberculosis

Up to 22% of new infections are of MDR-TB

top related